Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Gr: Cann Res in Urgent Areas-Cannabis in the context of pain management

McMaster University

$123,377.00

The effect of cannabidiol vs. placebo on persistent post-surgical pain following total knee arthroplasty: A multicenter, randomized pilot trial

FY 2018-19

Summary
Each year, about 67,000 Canadians undergo knee replacement surgery, and approximately 20% develop persistent post-surgical pain; a complaint that is associated with depression, anxiety, unemployment and reduced quality of life. Moreover, chronic pain after surgery is often managed with opioid therapy, which typically provides only modest benefits and is associated with rare but serious adverse events, such as overdose and death. A number of studies have found that greater pain just before and after knee replacement surgery is associated with the development of chronic pain, suggesting that reducing peri-operative pain may help prevent persistent post-surgical pain. Medicinal cannabis has begun to emerge as a potential therapy for pain reduction and produces effects largely due to 2 active components: (1) cannabidiol (CBD), and (2) tetrahydrocannabinol (THC). Studies of CBD have shown analgesic, anti-inflammatory, and anti-anxiety properties, but without the psychoactive effects (feeling 'high') that THC produces. We plan to assess the feasibility of a definitive trial to explore whether adding CBD vs. placebo to usual care before and after surgery can reduce the rate of persistent post-surgical pain after total knee replacement. Our pilot study will randomize 40 patients to receive either CBD or placebo, and follow them for six months to confirm our ability to recruit patients, adhere to protocol, and capture full outcome data for at least 90% of patients.
Program
Catalyst Gr: Cann Res in Urgent Areas-Cannabis in the context of pain management
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
403964
Name
Busse Jason W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Cannabis Research in Urgent Priority Areas
Projecttitle
The effect of cannabidiol vs. placebo on persistent post-surgical pain following total knee arthroplasty: A multicenter, randomized pilot trial
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$123,377
Cihrequipment2
$0
Programname2
Catalyst Gr: Cann Res in Urgent Areas-Cannabis in the context of pain management
Keyworddelim
Arthroplasty, Replacement, Knee; Medicinal Cannabis; Persistent Post Surgical Pain
Abstract
Each year, about 67,000 Canadians undergo knee replacement surgery, and approximately 20% develop persistent post-surgical pain; a complaint that is associated with depression, anxiety, unemployment and reduced quality of life. Moreover, chronic pain after surgery is often managed with opioid therapy, which typically provides only modest benefits and is associated with rare but serious adverse events, such as overdose and death. A number of studies have found that greater pain just before and after knee replacement surgery is associated with the development of chronic pain, suggesting that reducing peri-operative pain may help prevent persistent post-surgical pain. Medicinal cannabis has begun to emerge as a potential therapy for pain reduction and produces effects largely due to 2 active components: (1) cannabidiol (CBD), and (2) tetrahydrocannabinol (THC). Studies of CBD have shown analgesic, anti-inflammatory, and anti-anxiety properties, but without the psychoactive effects (feeling 'high') that THC produces. We plan to assess the feasibility of a definitive trial to explore whether adding CBD vs. placebo to usual care before and after surgery can reduce the rate of persistent post-surgical pain after total knee replacement. Our pilot study will randomize 40 patients to receive either CBD or placebo, and follow them for six months to confirm our ability to recruit patients, adhere to protocol, and capture full outcome data for at least 90% of patients.
Competitiondate
201810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Busse, Jason W; Adili, Anthony
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $75,000~ $0~Inst of Neurosc Mental Hlth &A~ $48,377~ $0~
McMaster University - $123,377 Grant (2018-19) | Canada Spends